The scrip of Indian leading drug maker managed by mnc,looking strong on the bourses in recent times.... the scrip is capable of achieving target of 500 in the near term....
i feel move was bit fast so i sold my 1 lot of december sereis at 495 (tri stop loss hit) made good profit looks like market is still strugling to cross 5200
30% appreciation is possible in this counter within two years.... at the moment,not expecting more than that even in the long term.... better exit on rises....
| NIFTY 
